Fulton Bank, N.A. Seagen Inc. Transaction History

Fulton Bank, N.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 05, 2022	SELL	$119.61 - $157.85 $349,500 - $461,237	-2,922 Closed	0 $0
Q4 2021 Jan 05, 2022	SELL	$142.57 - $190.86 $66,295 - $88,749	-465 Reduced 13.73%	2,922 $452,000
Q3 2021 Oct 05, 2021	SELL	$142.45 - $169.82 $472,791 - $563,632	-3,319 Reduced 49.49%	3,387 $575,000
Q2 2021 Jul 06, 2021	SELL	$135.08 - $161.1 $2,026 - $2,416	-15 Reduced 0.22%	6,706 $1.06 Million
Q1 2021 Apr 05, 2021	BUY	$137.51 - $190.8 $25,576 - $35,488	186 Added 2.85%	6,721 $934,000

Q4 2020 Jan 07, 2021	BUY	$164.63 - $211.93 $1.08 Million - $1.38 Million	6,535 New	6,535 $1.14 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Fulton Bank, N.A. with notifications on news.